tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 978 are a BUY (93.32%), 67 are a HOLD (6.39%), 3 are a SELL (0.29%).
Analyst Raghuram Selvaraju, carries an average stock price target met ratio of 31.5% that have a potential upside of 47.75% achieved within 181 days. Previously, Raghuram Selvaraju worked at HC WAINWRIGHT.
Raghuram Selvaraju’s has documented 1,946 price targets and ratings displayed on 111 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on AXSM, Axsome Therapeutics at 22-May-2025.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for EVOK (EVOKE PHARMA) at 7/18/2016. The price target of $288 was fulfilled within 3 days with a profit of $128.16 (30.8%) receiving and performance score of 102.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$7
$-4.59 (-39.60%)
$20
1 months 19 days ago
(17-Apr-2025)
8/12 (66.67%)
$-2.11 (-23.16%)
55
Buy
11 months 18 days ago
(18-Jun-2024)
10/37 (27.03%)
$101 (102.02%)
298
Sell
1 years 6 months 16 days ago
(20-Nov-2023)
1/3 (33.33%)
$-0.8 (-0.99%)
300
Hold
$20
$8.41 (72.56%)
$60
1 years 7 months 11 days ago
(25-Oct-2023)
3/22 (13.64%)
$5.72 (40.06%)
40
Hold
$25
$13.41 (115.70%)
$40
1 years 10 months 17 days ago
(19-Jul-2023)
2/5 (40%)
$3.4 (15.74%)
215
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
